T cell‐mediated tumor cell killing assay

AW Ailing Wu
QW Qingzhe Wu
YD Yujie Deng
YL Yuning Liu
JL Jinqiu Lu
LL Liansheng Liu
XL Xiaoling Li
CL Cheng Liao
BZ Bin Zhao
HS Hai Song
request Request a Protocol
ask Ask a question
Favorite

T cells were activated and expanded from peripheral blood mononuclear cells (PBMCs) of healthy donors using Dynabeads® Human T‐Activator CD3/CD28 (Gibco, 11161D) and IL‐2 (10 ng/ml; Peprotech). To analyze the killing of tumor cells by T cells, we co‐cultured tumor cells with activated primary human T cells in 24‐well plates for 4 days. To visualize the survived tumor cells at the end point, wells were washed with PBS twice to remove T cells, and then, the survived tumor cells were fixed and stained with crystal violet solution. The pictures of the dried plates were taken, and the intensity was quantified.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A